Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Gobbini

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cell Reports|March 31, 2021
Sae2 and Rif2 regulate MRX endonuclease activity at DNA double-strand breaks in opposite mannersAntonio Marsella, Elisa Gobbini, Corinne Cassani, et al.
Clinical Lung Cancer|November 24, 2016
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysisAnna La Salvia, Antonio Rossi, Domenico Galetta, et al.
Oncoimmunology|November 14, 2025
Dendritic cells: the central partner for cancer immunityLéo Laoubi, Elisa Gobbini, Pierre Duplouye, et al.
Frontiers in Medicine|November 19, 2019
Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized MedicineJulian Pinsolle, Anne McLeer-Florin, Matteo Giaj Levra, et al.
Nucleic Acids Research|February 9, 2018
Structurally distinct Mre11 domains mediate MRX functions in resection, end-tethering and DNA damage resistanceCorinne Cassani, Elisa Gobbini, Jacopo Vertemara, et al.
Cancers|October 29, 2020
Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung CancerElisa Gobbini, Aurélie Swalduz, Matteo Giaj Levra, et al.
Oncology and Therapy|May 3, 2026
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST StudyBenoît Godbert, Elisa Gobbini, Yaacoub Khalife, et al.
Bulletin Du Cancer|November 17, 2021
Immune checkpoint inhibitors and hospitalization at home in FranceElisa Gobbini, Anne-Claire Toffart, Laure Boisserie Lacroix, et al.
The EMBO Journal|June 22, 2018
The MRX complex regulates Exo1 resection activity by altering DNA end structureElisa Gobbini, Corinne Cassani, Jacopo Vertemara, et al.
Cancer Research|July 9, 2026
Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung CancerTriparna Sen, Elisa Gobbini, Khalis Mustafayev, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cell Reports|March 31, 2021
Sae2 and Rif2 regulate MRX endonuclease activity at DNA double-strand breaks in opposite mannersAntonio Marsella, Elisa Gobbini, Corinne Cassani, et al.
Clinical Lung Cancer|November 24, 2016
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysisAnna La Salvia, Antonio Rossi, Domenico Galetta, et al.
Oncoimmunology|November 14, 2025
Dendritic cells: the central partner for cancer immunityLéo Laoubi, Elisa Gobbini, Pierre Duplouye, et al.
Frontiers in Medicine|November 19, 2019
Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized MedicineJulian Pinsolle, Anne McLeer-Florin, Matteo Giaj Levra, et al.
Nucleic Acids Research|February 9, 2018
Structurally distinct Mre11 domains mediate MRX functions in resection, end-tethering and DNA damage resistanceCorinne Cassani, Elisa Gobbini, Jacopo Vertemara, et al.
Cancers|October 29, 2020
Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung CancerElisa Gobbini, Aurélie Swalduz, Matteo Giaj Levra, et al.
Oncology and Therapy|May 3, 2026
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST StudyBenoît Godbert, Elisa Gobbini, Yaacoub Khalife, et al.
Bulletin Du Cancer|November 17, 2021
Immune checkpoint inhibitors and hospitalization at home in FranceElisa Gobbini, Anne-Claire Toffart, Laure Boisserie Lacroix, et al.
The EMBO Journal|June 22, 2018
The MRX complex regulates Exo1 resection activity by altering DNA end structureElisa Gobbini, Corinne Cassani, Jacopo Vertemara, et al.
Cancer Research|July 9, 2026
Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung CancerTriparna Sen, Elisa Gobbini, Khalis Mustafayev, et al.
Pageof 5